Willingness to pay for cancer prevention versus treatment in China: implications for cost-effectiveness threshold-Reference-Cited by-同舟云学术

Willingness to pay for cancer prevention versus treatment in China: implications for cost-effectiveness threshold

Published:2023-09-29 Issue:1 Volume:24 Page:155-160
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Zhao Zixuan¹^ORCID,Yang Yi²,Wu Weijia²,Dong Hengjin²

Affiliation:

1. Department of Public Administration, School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China

2. Department of Science and Education of the Fourth Affiliated Hospital, and Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China

Funder

Scientific Research Foundation of Nanjing University of Chinese Medicine

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2262141

Reference43 articles.

1. Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions

2. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations;Laupacis A;CMAJ

3. Healthcare Rationing by Proxy

4. Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

5. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing deep learning for the comprehensive forecast model in flue gas desulfurization systems;Control Engineering Practice;2023-09